Status:
ACTIVE_NOT_RECRUITING
Optimizing the Treatment Strategy for Age-related Macular Degeneration
Lead Sponsor:
St. Olavs Hospital
Collaborating Sponsors:
Norwegian University of Science and Technology
Molde Hospital
Conditions:
Wet Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare two different treatment protocols for wet macular degeneration; the new protocol called "Observe and Plan" against the current standard protocol "Treat and Exte...
Detailed Description
The purpose of the study is to test a new treatment protocol for wet macular degeneration, called "Observe and Plan", against today's standard protocol "Treat and Extend". Studies suggest that the ind...
Eligibility Criteria
Inclusion
- diagnosed age-related macular degeneration according to criteria.
- new diagnose of active CNV verified with OCTA or FA / ICGA.
- BCVA ≥ 20/200 measured with ETDRS visual acuity chart
- written informed consent
Exclusion
- Eyes formerly treated with anti-VEGF, photodynamic therapy, radiation therapy, transpupillary thermotherapy or focal laser photocoagulation involving the macular area.
- Geographic atrophy and subretinal fibrosis affecting the patient's visual acuity.
- Any other ongoing eye disease that influences patient's visual acuity, such as glaucoma with central vision loss, proliferative diabetic retinopathy, diabetic macular edema or chronic uveitis.
Key Trial Info
Start Date :
May 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04420923
Start Date
May 20 2020
End Date
September 1 2026
Last Update
June 8 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Ålesund Hospital
Ålesund, Norway
2
Molde Hospital
Molde, Norway
3
Dept. of Ophthalmology, St Olavs Hospital, Trondheim University Hospital
Trondheim, Norway, N-7006